Overcoming Regulatory Challenges and Building Community Trust for a SARS-CoV-2 Vaccine

Learn more about the FDA and regulatory restrictions related to SARS-CoV-2 vaccines and the challenges in distribution to the general public


Thomas A Buchanan, Professor of Medicine, Bernard J. Hanley Chair in Medicine, Vice Dean for Research, Director of the CTSI,Co-Director, Diabetes and Obesity Research Institute Endocrine Division Chief in the Department of Medicine

Steven W. Chen, PharmD, FASHP, FCSHP, FNAP Associate Dean for Clinical Affairs William A. and Josephine A. Heeres Chair in Community Pharmacy Professor of Clinical Pharmacy USC School of Pharmacy

Michael P Dube, MD, Professor of Medicine (Clinical Scholar) Associate Medical Director of the Rand Schrader AIDs Clinic Interim Chief, Infectious Disease

Michele D. Kipke, PhD, Professor of Pediatrics (Clinical Scholar) Vice-Chair of Research at CHLA Keck School of Medicine of USC Institute Co-Director and Director of Community Engagement, SC CTSI

Eunjoo Pacifici, PharmD, PhD, Chair and Associate Professor of Regulatory and Quality Sciences USC School of Pharmacy Director, Regulatory Knowledge and Support, SC CTSI

Nancy Pire-Smerkanich, DRSc, MS, Assistant Professor of Regulatory and Quality Sciences USC School of Pharmacy Associate Director, Regulatory Knowledge and Support SC CTSI 

Additional resources from the presentation: 

NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.